Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops

References

• Weber MA. Rationalizing the treatment of hypertension. Am J Hypertens 2001;14:S3–S7
   PubMedGoogle Scholar
• Zhang K, Zhang L, Weinreb RN. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov 2012;11:541–559
   PubMed Web of Science ®Google Scholar
• Agarwal R, Krasilnikova AV, Safinaz RI, et al. Mechanisms of angiotensin converting enzyme inhibitor-induced IOP reduction in normotensive rats. Eur J Pharmacol 2014;730:8–13
   PubMed Web of Science ®Google Scholar
• Shah GB, Sharma S, Mehta AA, Goyal RK. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardoovasc Pharmacol 2000;36:169–175
   PubMed Web of Science ®Google Scholar
• Mehta A, Iyer L, Parmar S, et al. Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits. Can J Physiol Pharmacol 2010;88:595–600
   PubMed Web of Science ®Google Scholar
• Wang R-F, Podos SM, Mittag TW, Yokoyoma T. Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes. Exp Eye Res 2005;80:629–632
   PubMed Web of Science ®Google Scholar
• Loftsson T, Thorisdottir S, Fridriksdottir H, Stefansson E. Enalaprilat and enalapril maleate eye drops lower intraocular pressure in rabbits. Acta Opththalmol 2010;88:337–341
   PubMed Web of Science ®Google Scholar
• Vaajanen A, Luhtala S, Oksala O, Vapaatalo H. Does the renin-angiotensin system also regulate intra-ocular pressure? Ann. Med. 2008;40:418–427
   Google Scholar
• Costagliola C, Verolino M, de Rosa ML, et al. Effect of oral losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects. Exp Eye Res 2000;71:167–171
   PubMed Web of Science ®Google Scholar
• Abreu MM, Kim YY, Shin DH, Netland PA. Topical verapamil and episcleral venous pressure. Ophthalmol 1998;105:2251–2255
   PubMed Web of Science ®Google Scholar
• Araie M, Mayama C. Use of calcium channel blockers for glaucoma. Prog Retin Eye Res 2011;30:54–71
   PubMed Web of Science ®Google Scholar
• Adake P, Somashekar HS, Gokul CG, et al. Ocular hypotensive effect of topical verapamil and diltiazem in steroid induced glaucoma model of rabbits. Br J Pharm Res 2013;3:1115–1126
   Google Scholar
• Abelson MB, Gilbert CM, Smith LM. Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil. Am J Ophthalmol 1988;105:155–159
   PubMed Web of Science ®Google Scholar
• Shayegan MR, Boloorian AA, Kianoush S. Comparative study of topical application of timolol and verapamil in patients with glaucoma within 6 months. J Ocul Pharmacol Ther 2009;25:551–553
   PubMed Web of Science ®Google Scholar
• Loftsson T, Konradsdottir F, Masson M. Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Pharmazie 2006;61:83–89
   PubMed Web of Science ®Google Scholar
• Loftsson T, Stefansson E. Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug. J Drug Del Sci Tech 2007;17:3–9
   Web of Science ®Google Scholar
• Jarvinen T, Jarvinen K, Urtti A, et al. Sulfobutyl ether β-cyclodextrin (SBE-β-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits. J Ocul Pharmacol Ther 1995;11:95–106
   PubMed Web of Science ®Google Scholar
• Jarho P, Jarvinen K, Urtti A, et al. Modified β-cyclodextrin (SBE7-β-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits. J Pharm Pharmacol 1996;48:263–269
   PubMed Web of Science ®Google Scholar
• Loftsson T, Stefansson E. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol Scand 2002;80:144–150
   PubMedGoogle Scholar
• Koutsou GA, Storey DM, Bar A. Gastrointestinal tolerance of γ-cyclodextrin in humans. Food Addit Contam 1999;16:313–317
   PubMed Web of Science ®Google Scholar
• Munro IC, Newberne PM, Young RR, Bar A. Safety assessment of γ-cyclodextrin. Regul Toxicol Pharmacol 2004;39:S3–S13
   PubMed Web of Science ®Google Scholar
• Loftsson T, Hreinsdóttir D, Stefánsson E. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops. J Pharm Pharmacol 2007;59:629–635
   PubMed Web of Science ®Google Scholar
• Jansook P, Stefánsson E, Thorsteinsdóttir M, et al. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop suspension. Eur J Pharm Biopharm 2010;76:208–214
   PubMedGoogle Scholar
• Yoshida MI, Gomes ECL, Soares CDV, et al. Thermal analysis applied to verapamil hydrochloride characterization in pharmaceutical formulations. Molecules 2010;15:2439–2452
   PubMed Web of Science ®Google Scholar
• Vujić Z, Mulavdić N, Smajić M, et al. Simultaneous analysis of irbesartan and hydrochlorothiazide: an improved HPLC method with the aid of a chemometric protocol. Molecules 2012;17:3461–3474
   PubMedGoogle Scholar
• Kane R, Naik S, Bumrela S, Kuchekar B. Preparation, physicochemical characterization, dissolution and formulation studies of irbesartan cyclodextrin inclusion complexes: comparison between β-CD & HP-β-CD. J Pharm Res 2009;2:1359–1364
   Google Scholar
• Loftsson T, Järvinen T. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 1999;36:59–79
   PubMed Web of Science ®Google Scholar
• Loftsson T, Sigurðsson HH, Konráðsdóttir F, et al. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations. Pharmazie 2008;63:171–179
   PubMed Web of Science ®Google Scholar
• Sugrue MF. The pharmacology of antiglaucoma drugs. Pharm Ther 1989;43:91–138
   PubMed Web of Science ®Google Scholar
• Chrai SS, Patton TF, Mehta A, Robinson JR. Lacrimal and instilled fluid dynamics in rabbit eye. J Pharm Sci 1973;62:1112–1121
   PubMed Web of Science ®Google Scholar
• Iliff NT. The Lacriminal Outflow System. In: Persin J, Evans GRD, eds. Soft-tissue surgery of the craniofacial region. New York: Informa Healthcare; 2007:129–155
   Google Scholar
• Loftsson T. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer. Pharmazie 2012;67:363–370
   PubMed Web of Science ®Google Scholar
• Chien DS, Bundgaard H, Lee VHL. Influence of corneal epithelial integrity on the penetration of timolol prodrugs. J Ocul Pharmacol 1988;4:137–146
   PubMedGoogle Scholar
• Pitkänen L, Ranta VP, Moilanen H, Urtti A. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Inv Ophthalm Vis Sci 2005;46:641–646
   PubMed Web of Science ®Google Scholar
• Gaudana R, Jwala J, Boddu SHS, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res 2009;26:1197–1216
   PubMed Web of Science ®Google Scholar
• Jordan J, Ruiz-Moreno JM. Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters. Exp Opin Drug Metab Toxicol 2013;9:1181–1192
   PubMed Web of Science ®Google Scholar
• Loftsson T. Self-assembled cyclodextrin nanoparticles and drug delivery. J Incl Phenom Macrocycl Chem 2014. [Epub ahead of print]. DOI: 10.1111/aos.12334
   Google Scholar
• Jóhannesson G, Moya-Ortega MD, Ásgrímsdóttir GM, et al. Kinetics of γ-cyclodextrin nanoparticle suspension eye drops in tear fluid. Acta Ophthalmol 2014. [Epub ahead of print]. DOI: 10.1007/s10847-013-0375-1
   Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. J Pharm Pharmacol 2011;63:1119–1135
   PubMed Web of Science ®Google Scholar
• Jansook P, Ritthidej GC, Ueda H, et al. γCD/HPγCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension. J Pharm Pharmaceut Sci 2010;13:336–350
   PubMed Web of Science ®Google Scholar
• Sigurdsson HH, Konrádsdóttir F, Loftsson T, Stefánsson E. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye. Acta Ophthalmol Scand 2007;85:598–602
   PubMedGoogle Scholar
• Loftsson T, Stefánsson E. Cyclodextrins in ocular drug delivery. J Drug Del Sci Tech 2007;17:3–9
   Web of Science ®Google Scholar
• Tanito M, Hara K, Takai Y, et al. Topical dexamethasone-cyclodextrin microparticle eye drops for diabetic macular edema. Invest. Ophthalmol Vis Sci 2011;52:7944–7948
   PubMed Web of Science ®Google Scholar
• Loftsson T, Hreinsdóttir D. Determination of aqueous solubility by heating and equilibration: a technical note. AAPS PharmSciTech. 2006;7:E29–E32
   Google Scholar
• Lokesh BVS, Naidu SR. New dissolution method for the evaluation of enalapril maleate tablets using pH 7.2 phosphate buffer in vitro and determination of its content by validated UV spectrophotometric method. J Acoust Soc Am 2007;121:34–37
   Google Scholar
• Chang ZL. Verapamil. In: Klaus F, ed. Analytical profiles of drug substances. Vol. 17. San Diego (CA): Academic Press, Inc.; 1988:643–662
   Google Scholar
• Laksami AP, Kumar MA, Krishna MV, et al. Formulation development of irbesartan (poorly water-soluble drug) immediate release tablets. Int Res J Pharm 2012;3:117–120
   Google Scholar
• Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum 1965;4:117–212
   Google Scholar
• Loftsson T, Hreinsdottir D, Masson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 2005;302:18–28
   PubMed Web of Science ®Google Scholar
• González-Gaitano G, Rodríguez P, Isasi JR, et al. The aggregation of cyclodextrins as studied by photon correlation spectroscopy. J Incl Phenom Macrocycl Chem 2002;44:101–105
   Web of Science ®Google Scholar
• Ukhaskaya EV, Kurkov SV, Matthews SE, et al. Evaluation of a cationic calix[4]arene: solubilization and self-aggregation ability. Int J Pharm 2010;402:10–19
   PubMedGoogle Scholar
• Loftsson T, Magnúsdóttir A, Másson M, et al. Self-association and cyclodextrin solubilization of drugs. J Pharm Sci 2002;91:2307–2316
   PubMed Web of Science ®Google Scholar
• Loftsson T, Másson M, Brewster ME. Self-association of cyclodextrins and cyclodextrin complexes. J Pharm Sci 2004;93:1091–1099
   PubMed Web of Science ®Google Scholar
• Messner M, Kurkov SV, Flavià-Piera R, et al. Self-assembly of cyclodextrin complexes: the effect of the guest molecule. Int J Pharm 2011;408:235–247
   PubMedGoogle Scholar
• Messner M, Kurko SV, Palazón MM, et al. Self-assembly of cyclodextrin complexes: effect of temperature, agitation and media composition on aggregation. Int J Pharm 2011;419:322–328
   PubMed Web of Science ®Google Scholar